Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/31/2005WO2005028671A2 Method for determining hair cycle markers
03/31/2005WO2005028670A1 A method for polymerase chain reaction
03/31/2005WO2005028669A1 Time-of-addition assay for identifying anti-viral compounds
03/31/2005WO2005028668A1 General method for enrichment and detection of pathogen bacteria
03/31/2005WO2005028666A2 Determining kinase specificity
03/31/2005WO2005028660A1 PROCESS FOR PRODUCING α-GLYCOSYLATED DIPEPTIDE AND METHOD OF ASSAYING α-GLYCOSYLATED DIPEPTIDE
03/31/2005WO2005028657A2 Excretable reporter systems
03/31/2005WO2005028648A1 Disease type of lymphoma and method of assessing prognosis
03/31/2005WO2005028647A1 Nucleic acid probe, nucleic acid chip, method of detecting target nucleic acid, method of screening drug, apparatus for detecting target nucleic acid and gene diagnosis method
03/31/2005WO2005028645A1 SNPs IN 5’ REGULATORY REGION OF MDR1 GENE
03/31/2005WO2005028635A2 Microfluidic differential extraction cartridge
03/31/2005WO2005028629A2 Whole genome expression analysis system
03/31/2005WO2005028621A2 Assays with primary cells
03/31/2005WO2005028620A2 Histone modifications as binary switches controlling gene expression
03/31/2005WO2005028617A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas
03/31/2005WO2005028615A2 Methods and compositions for detecting promoter activity and expressing fusion proteins
03/31/2005WO2005028613A2 Method for functionally screening agents which can modulate the activity of ubiquitine hydrolases and uses thereof.
03/31/2005WO2005028503A1 Peptide originating in hepatitis c virus
03/31/2005WO2005028424A1 Whole cell assay involving cathepsin s
03/31/2005WO2005028110A2 Microplates useful for conducting thermocycled nucleotide amplification
03/31/2005WO2005028109A2 Microplates useful for conducting thermocycled nucleotide amplification
03/31/2005WO2005027962A1 4’-thionucleosides and oligomeric compounds
03/31/2005WO2005027886A2 Methods of preventing or treating recurrence of myocardial infarction
03/31/2005WO2005027854A2 T cell regulatory genes associated with immune disease
03/31/2005WO2005027831A2 Modulators of p-selectin glycoprotein ligand 1
03/31/2005WO2005027731A2 Biagnostic system for otolaryngologic pathogens and use thereof
03/31/2005WO2005027727A2 Use of pin1 inhibitors for treatment of cancer
03/31/2005WO2005027723A2 Real time assay for rotavirus
03/31/2005WO2005027719A2 Methods and systems for identifying predisposition to the placebo effect
03/31/2005WO2005027716A2 Program for regulating health conditions
03/31/2005WO2005027715A2 CRYSTALS AND STRUCTURES OF SARS-CoV MAIN PROTEASE
03/31/2005WO2005027714A2 Sensitive and rapid biodetection
03/31/2005WO2005027713A2 Compositions, splice variants and methods relating to colon specific genes and proteins
03/31/2005WO2005027712A2 Methods of diagnosing, prognosing and treating breast cancer
03/31/2005WO2005027634A1 Apparatus and methods for selecting capacitated spermatozoa and uses thereof
03/31/2005WO2005019259A3 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/31/2005WO2005017205A3 Nucleic acid mapping using linear analysis
03/31/2005WO2005012556A3 Cationic anti-microbial peptides and methods of use thereof
03/31/2005WO2005007874A3 Sequential generation of multiple chemiluminescent signals on solid supports
03/31/2005WO2005007822A3 Method for assaying protein-protein interaction
03/31/2005WO2005003387A3 Specific method of prostate cancer detection based on pca3 gene, and kits therefor
03/31/2005WO2005003378A3 Methods for analyzing transcripts
03/31/2005WO2005001477A3 Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
03/31/2005WO2005001114A3 Screening methods
03/31/2005WO2004112829A3 Compositions and methods for the diagnosis and treatment of tumors of glial origin
03/31/2005WO2004104224A3 Markers for lxr activation
03/31/2005WO2004094713A3 System and method for marking textiles with nucleic acids
03/31/2005WO2004093645A3 Tn5 transposase mutants and the use thereof
03/31/2005WO2004092740A3 Methods for identifying therapeutic targets involved in glucose and lipid metabolism
03/31/2005WO2004087076A3 Methods for inhibiting adipogenesis and for treating type 2 diabetes
03/31/2005WO2004087062A3 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
03/31/2005WO2004085682A3 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza
03/31/2005WO2004083406A3 Genes that are up- or down-regulated during differentiation of human embryonic stem cells
03/31/2005WO2004081181A3 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
03/31/2005WO2004079014A3 Signatures of er status in breast cancer
03/31/2005WO2004078020A3 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia
03/31/2005WO2004076690A3 Use of a mutation in the human gnas gene for predicting risks of disease, courses of diseases, and for predicting the response to treatments of disease
03/31/2005WO2004075839A3 Methods and compositions for modulating apoptosis
03/31/2005WO2004074441A3 Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto
03/31/2005WO2004073499A3 Diagnosis of primary open angle glaucoma
03/31/2005WO2004068110A3 Methods of predicting mortality risk by determining telomere length
03/31/2005WO2004064748A3 Compositions and methods for treatment of ovarian cancer
03/31/2005WO2004064711A3 Modulation of deubiquitinase family members
03/31/2005WO2004063712A3 Methods for diagnosis and prognosis of cancer
03/31/2005WO2004063709A8 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
03/31/2005WO2004060320A3 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
03/31/2005WO2004059293A3 Markers for differential diagnosis and methods of use thereof
03/31/2005WO2004058990A3 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
03/31/2005WO2004051226A3 Monitoring high-risk environments
03/31/2005WO2004048522A3 Modulation of huntingtin interacting protein 2 expression
03/31/2005WO2004048325A3 Modulation of jagged 1 expression
03/31/2005WO2004045547A3 Rnai-based sensors, caged interfering rnas, and methods of use thereof
03/31/2005WO2004043371A3 Methods and compositions for modulating p53 transcription factor
03/31/2005WO2004041192A3 Panels of molecular targets differentially expressed during cd8+ t-cell priming
03/31/2005WO2004036221A3 Compositions and methods for diagnosing and treating autoimmune disease
03/31/2005WO2004010108A9 Method for the identification of ligands
03/31/2005WO2003099215A3 Antisense modulation of glucocorticoid receptor expression
03/31/2005WO2003073987A3 Compounds that modulate the activity of ptp-1b and tc-ptp
03/31/2005WO2003054143A3 Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
03/31/2005WO2003044178A8 Hybrid oligonucleotide primers for amplification of dna and uses thereof
03/31/2005WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/31/2005WO2003027308A3 56294 and 56629, novel human metalloproteases and uses thereof
03/31/2005WO2003018756A3 Methods for preparing purified prostaglandin e synthase
03/31/2005WO2003014699A3 Compositions and methods for detecting and quantifying cox-2 activity by lipoamino acid metabolism
03/31/2005WO2002099054A3 Hccss as modifiers of the p53 pathway and methods of use
03/31/2005US20050071901 Soybean plants having superior agronomic performance and methods for their production
03/31/2005US20050071899 Nucleotide sequences comprising stilbene synthase regulatory region for use as tool in enhancing ozone resistance in plants; improving crop yields; delaying senescence
03/31/2005US20050071892 Techniques and applications of establishment of SARS-CoV primate model
03/31/2005US20050071088 Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment
03/31/2005US20050071087 Systems and methods for detecting biological features
03/31/2005US20050070708 May be used for the analysis of nucleic acid sequences by incorporating these derivatives into nucleic acid chains, and also the enzymatic labelling and immobilization or detection of sequences
03/31/2005US20050070701 Detection of living cells in polymers or pigments
03/31/2005US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders
03/31/2005US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders
03/31/2005US20050070567 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
03/31/2005US20050070515 Glucocorticosteroids which are hydrolysable in human or animal blood by lactonase enzyme; for treatment of respiratory and gastrointestinal disorders; side effect reduction
03/31/2005US20050070499 Administering neuropeptide y inhibitor
03/31/2005US20050070491 Immunostimulatory nucleic acid molecules
03/31/2005US20050070015 Methods of controlling proliferation of cancer cells and cell death
03/31/2005US20050070011 Method and device for replicating arrays of cell colonies
1 ... 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 ... 3003